NATIONAL DRUG POLICIES - THE NEED FOR DRUG UTILIZATION STUDIES

被引:25
|
作者
BAKSAAS, I
LUNDE, PKM
机构
关键词
D O I
10.1016/0165-6147(86)90375-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:331 / 334
页数:4
相关论文
共 50 条
  • [1] NATIONAL DRUG POLICIES
    不详
    WHO CHRONICLE, 1975, 29 (09) : 337 - 349
  • [2] NATIONAL DRUG POLICIES
    LAING, RO
    ROSSDEGNAN, DG
    LANCET, 1995, 346 (8989): : 1561 - 1562
  • [3] NEED FOR DRUG UTILIZATION REVIEW
    RUCKER, TD
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1970, 27 (08): : 654 - &
  • [4] NATIONAL DRUG POLICIES - WHO
    不详
    PUBLIC HEALTH REVIEWS, 1979, 8 (04) : 407 - 407
  • [5] Comment.: Drug utilization studies.: The need to know the indication
    Caamano, Francisco
    GACETA SANITARIA, 2008, 22 (01) : 19 - 19
  • [6] IMPLICATIONS OF DRUG UTILIZATION STUDIES FOR DRUG SURVEILLANCE
    BUSTO, UE
    RECENT ADVANCES IN PHARMACOLOGY AND THERAPEUTICS, 1989, 839 : 169 - 172
  • [7] The Global Drug Policy Index: tracking national drug policies
    Thornton, Jacqui
    LANCET, 2021, 398 (10313): : 1788 - 1789
  • [8] A CRITICAL ANALYSIS OF STUDIES OF STATE DRUG REIMBURSEMENT POLICIES - RESEARCH IN NEED OF DISCIPLINE
    SOUMERAI, SB
    ROSSDEGNAN, D
    FORTESS, EE
    ABELSON, J
    MILBANK QUARTERLY, 1993, 71 (02): : 217 - 252
  • [9] Need for Multicriteria Evaluation of Generic Drug Policies
    Kalo, Zoltan
    Holtorf, Anke-Peggy
    Alfonso-Cristancho, Rafael
    Shen, Jie
    Agh, Tamas
    Inotai, Andras
    Brixner, Diana
    VALUE IN HEALTH, 2015, 18 (02) : 346 - 351
  • [10] Payer Drug and Molecular Testing Utilization Policies
    Bankhead, Charles
    AMERICAN HEALTH AND DRUG BENEFITS, 2012, 5 (06): : 345 - 346